AtriCure CSO Sells 5,000 Shares — A Modest Trim or a Pattern Worth Watching? | The Motley Fool
This medical device innovator for cardiac surgery reported a notable insider sale amid a year of negative total returns.
Source: The Motley Fool
This medical device innovator for cardiac surgery reported a notable insider sale amid a year of negative total returns.
